On November 22, 2022 Keros Therapeutics, Inc. ("Keros") (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological, pulmonary and cardiovascular disorders with high unmet medical need, reported that Keros’ President and Chief Executive Officer Jasbir S. Seehra, Ph.D., will participate in fireside chat presentations at the Piper Sandler 34th Annual Healthcare Conference and the 5th Annual Evercore ISI HealthCONx Conference (Press release, Keros Therapeutics, NOV 22, 2022, View Source [SID1234624340]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Fireside Chat Presentation Details

Piper Sandler 34th Annual Healthcare Conference
•Date and Time: Tuesday, November 29 at 10:00 a.m. Eastern time
•Link: A live audio webcast will be available at View Source;tp_key=815a14dcdc

5th Annual Evercore ISI HealthCONx Conference
•Date and Time: Thursday, December 1 at 8:50 a.m. Eastern time
•Link: A live audio webcast will be available at View Source

For each fireside chat, an archived replay will be available in the Investors section of the Keros website at View Source for 90 days following the conclusion of the event.